Dagui Lin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Ferroptosis and cancer prognosis 5
- Advanced Breast Cancer Therapies 3
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Yunfang Yu (11 shared papers)Yongjian Chen (8 shared papers)Qiyun Ou (11 shared papers)Anlin Li (6 shared papers)Herui Yao (10 shared papers)Shengbo Liu (2 shared papers)Haiyu Zhou (2 shared papers)Dongqiang Zeng (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)JAMA Network Open (2 papers)Cancer Research and Treatment (1 paper)Journal of Translational Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dagui Lin
15 papers receiving 427 citations
Peers
Comparison fields: 5 of 56
- Oncology 252
- Cancer Research 126
- Pulmonary and Respiratory Medicine 203
- Immunology 112
- Molecular Biology 130
Countries citing papers authored by Dagui Lin
This map shows the geographic impact of Dagui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagui Lin more than expected).
Fields of papers citing papers by Dagui Lin
This network shows the impact of papers produced by Dagui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagui Lin. The network helps show where Dagui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dagui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 200 | |
| 2 | 2021 | 67 | |
| 3 | 2021 | 42 | |
| 4 | 2021 | 32 | |
| 5 | 2024 | 23 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 17 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 7 | |
| 10 | 2024 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2023 | 0 | |
| 18 | 2022 | 0 |
About Dagui Lin
Dagui Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Immunology and Surgery, having authored 18 papers that have together received 428 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers), Ferroptosis and cancer prognosis (5 papers), Cancer Treatment and Pharmacology (3 papers), Advanced Breast Cancer Therapies (3 papers), Lung Cancer Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (252 citations), Cancer Research (126 citations), Pulmonary and Respiratory Medicine (203 citations), Immunology (112 citations) and Molecular Biology (130 citations). Dagui Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yunfang Yu, Yongjian Chen, Qiyun Ou, Anlin Li, Herui Yao, Shengbo Liu, Haiyu Zhou, Dongqiang Zeng, Wangjun Liao and Wenhao Zhou. Their work appears in journals such as Journal of Clinical Oncology, JAMA Network Open, Cancer Research and Treatment, Journal of Translational Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.